Global molecular cytogenetics market demand is anticipated to be valued at USD 2,761.9 Million in 2022, forecast a CAGR of 8.9% to be valued at USD 6,469.2 Million from 2022 to 2032. Growth is attributed to the changing methodologies for disease diagnosis and rising awareness about viral diseases and increasing government funding in various regions. From 2016 to 2021 a CAGR of 10.3% was registered for the enterprise key management market.
| Data Points | Key Statistics |
|---|---|
| Growth Rate (2016 to 2021) | 10.3% CAGR |
| Projected Growth Rate (2022 to 2032) | 8.9% CAGR |
| Expected Market Value (2022) | USD 2,761.9 Million |
| Anticipated Forecast Value (2032) | USD 6,469.2 Million |
Molecular cytogenetics comprises molecular biology and cytogenetics. Cytogenetics refers to the study of chromosomes and molecular cytogenetics further involves the analysis of genetic variations or alterations through in-situ hybridization techniques. Molecular cytogenetics finds crucial applications in the fields of biology and medicine.
Molecular cytogenetics studies the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression and evolution, and chromosomal abnormalities, particularly in medicinal and cancer-related genetics.
In molecular cytogenetics, techniques such as fluorescence in situ hybridization (FISH) are conducted wherein DNA probes are labeled with different colored fluorescent tags to visualize the whole genome or the most specific regions of the genome.
Also, the virtual karyotyping technique is done in molecular cytogenetics to assess the entire genome for the changes in the number of copies of the genome. FISH & GISH are one of the most reliable techniques for analyzing chromosomes.
The Growing Prevalence of Cancer to Boost the Growth of The Molecular Cytogenetics Market
Molecular cytogenetics provides a scan and analysis of the whole genome organization, its structure and behavior at high resolutions, and also the visualization of single peculiar genomic loci which is a major growth driver for the global molecular cytogenetics market.
The recent advances in the fields of molecular biology and cytogenetics have brought about several key developments in the research of mitosis and meiosis processes, chromosome structures and their subsequent manipulation, gene expression, regulation, and gene silencing techniques.
Molecular cytogenetics is primarily driven by cancer diagnostics which offers techniques for imaging in genetics, epigenetics, and cytology and can be utilized for chromosomal modifications. The increasing prevalence of cancer and subsequent requirement for accurate diagnosis is expected to boost the growth of the global molecular cytogenetics market from 2022 to 2032
Lack of Skilled professional May Impede the Growth of the Market
There are some factors that are expected to impede the growth of the molecular cytogenetics market over the analysis period, such as technical limitations and complexities associated with the equipment.
However, the high cost of cytogenetic instruments, and lack of awareness about advanced technological methodologies, especially in low and middle-income countries, and the high cost of sophisticated devices are also expected to hinder the market growth during the forecast period.
The growing demand for genetic tests is an opportunity for the global molecular cytogenetics market. However, strict regulatory frameworks and a lack of skilled professionals are some of the major challenges for the global molecular cytogenetics market.
Technically Advance Healthcare Sector in North America to Boost the Growth
North America is expected to accumulate a 31.2% revenue share in 2022. North America is the market leader regarding revenue in the global molecular cytogenetics market owing to the presence of a large number of clinical research laboratories and research & academic institutes.
The rise in the incidences of cancer, growing spending from government and private healthcare organizations, and improved healthcare infrastructure in this region also boost the molecular cytogenetics market.
For instance, the average probability of a woman in the United States acquiring breast cancer in her lifetime is about 13%. An estimated 234,030 new instances of lung cancer were discovered in 2018, and there are already 541,000 Americans who have been diagnosed with lung cancer at some time in their lives. These findings show the vast potential for development and expansion in the USA molecular cytogenetics market.
An Increase in R& D Activities in The Region Propels the Growth of the Market
According to Future Market Insights, Europe is expected to provide immense growth opportunities for molecular cytogenetics and is expected to accumulate 19.6% revenue in 2022.
Europe is expected to witness the largest market growth, owing to the presence of a huge population in need, a high birth rate, the rising caseload of pre and postnatal disorders, and an increasing number of cases of different types of cancer.
The growth of the market in the region is attributed to the increasing research and development activities, rise in government intervention, growing awareness regarding cancer molecular biomarkers, and improving healthcare infrastructure in the region.
Asia is expected to show high growth rates in the next five years in the molecular cytogenetics market. Some of the factors driving the growth of molecular cytogenetics in emerging markets are the increasing demand for genetic tests, advancements in healthcare infrastructure, and a large patient pool in countries such as India and China.
Also, the large number of research centers in China and India and Research and Development (R&D) centers in Japan will lead to a rise in demand for high-quality of molecular cytogenetics. Japan is the major contributor to the global molecular cytogenetics market mainly due to the well-established collaborations between manufacturers and research laboratories.
Also, the role of personalized medicine in the treatment of genetic or other disorders is gaining pace in developed countries and this factor is anticipated to unfold novel opportunities for the key players during the forecast period.
The new entrants in the molecular cytogenetics market are continually indulging in several collaborations and highly investing in research and development activities to provide more convenient solutions to industry verticals. Some of the major start-ups that are leading the development of the market are -Cepheid, Map my Genome, and Medgenome.
Some of the key participants present in the global molecular cytogenetics market include Thermo Fisher Scientific Inc., GeneDx, CytoTest Inc., Empire Genomics, Abbott Laboratories, Agilent Technologies, Biological Industries, and PerkinElmer Inc. among others.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Thermo Fisher Scientific Inc., GeneDx, CytoTest Inc., Empire Genomics, and Abbott Laboratories account for considerable market size, several regional-level players are also operating across key growth regions, particularly in the Asia Pacific.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.9% from 2022 to 2032 |
| Expected Market Value (2022) | USD 2,761.9 Million |
| Anticipated Forecast Value (2032) | USD 6,469.2 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Technique Type, Product Type, End User, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East and Africa |
| Key Countries Profiled | The USA, Canada, Mexico, Brazil, Germany, Italy, France, The United Kingdom, Spain, China, Japan, South Korea, Malaysia, Singapore, Australia, GCC, South Africa, Israel |
| Key Companies Profiled | Thermo Fisher Scientific Inc.; GeneDx; CytoTest Inc.; Empire Genomics; Abbott Laboratories; Agilent Technologies; Biological Industries; PerkinElmer Inc.; Bio-RAD Laboratories Inc.; F. Hoffmann-La Roche AG |
| Customization | Available Upon Request |
Table 01: Global Market Value (US$ million) Forecast by Region, 2016 to 2032
Table 02: Global Market Value (US$ million) Forecast by Technique Type, 2016 to 2032
Table 03: Global Market Value (US$ million) Forecast by Product Type, 2016 to 2032
Table 04: Global Market Value (US$ million) Forecast by End User, 2016 to 2032
Table 05: North America Market Value (US$ million) Forecast by Country, 2016 to 2032
Table 06: North America Market Value (US$ million) Forecast by Technique Type, 2016 to 2032
Table 07: North America Market Value (US$ million) Forecast by Product Type, 2016 to 2032
Table 08: North America Market Value (US$ million) Forecast by End User, 2016 to 2032
Table 09: Latin America Market Value (US$ million) Forecast by Country, 2016 to 2032
Table 10: Latin America Market Value (US$ million) Forecast by Technique Type, 2016 to 2032
Table 11: Latin America Market Value (US$ million) Forecast by Product Type, 2016 to 2032
Table 12: Latin America Market Value (US$ million) Forecast by End User, 2016 to 2032
Table 13: Europe Market Value (US$ million) Forecast by Country, 2016 to 2032
Table 14: Europe Market Value (US$ million) Forecast by Technique Type, 2016 to 2032
Table 15: Europe Market Value (US$ million) Forecast by Product Type, 2016 to 2032
Table 16: Europe Market Value (US$ million) Forecast by End User, 2016 to 2032
Table 17: Asia Pacific Market Value (US$ million) Forecast by Country, 2016 to 2032
Table 18: Asia Pacific Market Value (US$ million) Forecast by Technique Type, 2016 to 2032
Table 19: Asia Pacific Market Value (US$ million) Forecast by Product Type, 2016 to 2032
Table 20: Asia Pacific Market Value (US$ million) Forecast by End User, 2016 to 2032
Table 21: MEA Market Value (US$ million) Forecast by Country, 2016 to 2032
Table 22: MEA Market Value (US$ million) Forecast by Technique Type, 2016 to 2032
Table 23: MEA Market Value (US$ million) Forecast by Product Type, 2016 to 2032
Table 24: MEA Market Value (US$ million) Forecast by End User, 2016 to 2032
Figure 01: Global Market Value (US$ million) by Technique Type, 2022 to 2032
Figure 02: Global Market Value (US$ million) by Product Type, 2022 to 2032
Figure 03: Global Market Value (US$ million) by End User, 2022 to 2032
Figure 04: Global Market Value (US$ million) by Region, 2022 to 2032
Figure 05: Global Market Value (US$ million) Analysis by Region, 2016 to 2032
Figure 06: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 07: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 08: Global Market Value (US$ million) Analysis by Technique Type, 2016 to 2032
Figure 09: Global Market Value Share (%) and BPS Analysis by Technique Type, 2022 to 2032
Figure 10: Global Market Y-o-Y Growth (%) Projections by Technique Type, 2022 to 2032
Figure 11: Global Market Value (US$ million) Analysis by Product Type, 2016 to 2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 14: Global Market Value (US$ million) Analysis by End User, 2016 to 2032
Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 17: Global Market Attractiveness by Technique Type, 2022 to 2032
Figure 18: Global Market Attractiveness by Product Type, 2022 to 2032
Figure 19: Global Market Attractiveness by End User, 2022 to 2032
Figure 20: Global Market Attractiveness by Region, 2022 to 2032
Figure 21: North America Market Value (US$ million) by Technique Type, 2022 to 2032
Figure 22: North America Market Value (US$ million) by Product Type, 2022 to 2032
Figure 23: North America Market Value (US$ million) by End User, 2022 to 2032
Figure 24: North America Market Value (US$ million) by Country, 2022 to 2032
Figure 25: North America Market Value (US$ million) Analysis by Country, 2016 to 2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 28: North America Market Value (US$ million) Analysis by Technique Type, 2016 to 2032
Figure 29: North America Market Value Share (%) and BPS Analysis by Technique Type, 2022 to 2032
Figure 30: North America Market Y-o-Y Growth (%) Projections by Technique Type, 2022 to 2032
Figure 31: North America Market Value (US$ million) Analysis by Product Type, 2016 to 2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 34: North America Market Value (US$ million) Analysis by End User, 2016 to 2032
Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 37: North America Market Attractiveness by Technique Type, 2022 to 2032
Figure 38: North America Market Attractiveness by Product Type, 2022 to 2032
Figure 39: North America Market Attractiveness by End User, 2022 to 2032
Figure 40: North America Market Attractiveness by Country, 2022 to 2032
Figure 41: Latin America Market Value (US$ million) by Technique Type, 2022 to 2032
Figure 42: Latin America Market Value (US$ million) by Product Type, 2022 to 2032
Figure 43: Latin America Market Value (US$ million) by End User, 2022 to 2032
Figure 44: Latin America Market Value (US$ million) by Country, 2022 to 2032
Figure 45: Latin America Market Value (US$ million) Analysis by Country, 2016 to 2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 48: Latin America Market Value (US$ million) Analysis by Technique Type, 2016 to 2032
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Technique Type, 2022 to 2032
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Technique Type, 2022 to 2032
Figure 51: Latin America Market Value (US$ million) Analysis by Product Type, 2016 to 2032
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 54: Latin America Market Value (US$ million) Analysis by End User, 2016 to 2032
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 57: Latin America Market Attractiveness by Technique Type, 2022 to 2032
Figure 58: Latin America Market Attractiveness by Product Type, 2022 to 2032
Figure 59: Latin America Market Attractiveness by End User, 2022 to 2032
Figure 60: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 61: Europe Market Value (US$ million) by Technique Type, 2022 to 2032
Figure 62: Europe Market Value (US$ million) by Product Type, 2022 to 2032
Figure 63: Europe Market Value (US$ million) by End User, 2022 to 2032
Figure 64: Europe Market Value (US$ million) by Country, 2022 to 2032
Figure 65: Europe Market Value (US$ million) Analysis by Country, 2016 to 2032
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 68: Europe Market Value (US$ million) Analysis by Technique Type, 2016 to 2032
Figure 69: Europe Market Value Share (%) and BPS Analysis by Technique Type, 2022 to 2032
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Technique Type, 2022 to 2032
Figure 71: Europe Market Value (US$ million) Analysis by Product Type, 2016 to 2032
Figure 72: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 74: Europe Market Value (US$ million) Analysis by End User, 2016 to 2032
Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 77: Europe Market Attractiveness by Technique Type, 2022 to 2032
Figure 78: Europe Market Attractiveness by Product Type, 2022 to 2032
Figure 79: Europe Market Attractiveness by End User, 2022 to 2032
Figure 80: Europe Market Attractiveness by Country, 2022 to 2032
Figure 81: Asia Pacific Market Value (US$ million) by Technique Type, 2022 to 2032
Figure 82: Asia Pacific Market Value (US$ million) by Product Type, 2022 to 2032
Figure 83: Asia Pacific Market Value (US$ million) by End User, 2022 to 2032
Figure 84: Asia Pacific Market Value (US$ million) by Country, 2022 to 2032
Figure 85: Asia Pacific Market Value (US$ million) Analysis by Country, 2016 to 2032
Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 88: Asia Pacific Market Value (US$ million) Analysis by Technique Type, 2016 to 2032
Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Technique Type, 2022 to 2032
Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Technique Type, 2022 to 2032
Figure 91: Asia Pacific Market Value (US$ million) Analysis by Product Type, 2016 to 2032
Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 94: Asia Pacific Market Value (US$ million) Analysis by End User, 2016 to 2032
Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 97: Asia Pacific Market Attractiveness by Technique Type, 2022 to 2032
Figure 98: Asia Pacific Market Attractiveness by Product Type, 2022 to 2032
Figure 99: Asia Pacific Market Attractiveness by End User, 2022 to 2032
Figure 100: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 101: MEA Market Value (US$ million) by Technique Type, 2022 to 2032
Figure 102: MEA Market Value (US$ million) by Product Type, 2022 to 2032
Figure 103: MEA Market Value (US$ million) by End User, 2022 to 2032
Figure 104: MEA Market Value (US$ million) by Country, 2022 to 2032
Figure 105: MEA Market Value (US$ million) Analysis by Country, 2016 to 2032
Figure 106: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 107: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 108: MEA Market Value (US$ million) Analysis by Technique Type, 2016 to 2032
Figure 109: MEA Market Value Share (%) and BPS Analysis by Technique Type, 2022 to 2032
Figure 110: MEA Market Y-o-Y Growth (%) Projections by Technique Type, 2022 to 2032
Figure 111: MEA Market Value (US$ million) Analysis by Product Type, 2016 to 2032
Figure 112: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 113: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 114: MEA Market Value (US$ million) Analysis by End User, 2016 to 2032
Figure 115: MEA Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 116: MEA Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 117: MEA Market Attractiveness by Technique Type, 2022 to 2032
Figure 118: MEA Market Attractiveness by Product Type, 2022 to 2032
Figure 119: MEA Market Attractiveness by End User, 2022 to 2032
Figure 120: MEA Market Attractiveness by Country, 2022 to 2032
FMI projects the global molecular cytogenetics market to expand at an 8.9% value CAGR by 2032
North America is expected to be the most opportunistic with a 31.2% share of the total molecular cytogenetics market
Thermo Fisher Scientific Inc., GeneDx, CytoTest Inc., Empire Genomics, Abbott Laboratories are some prominent molecular cytogenetics market manufacturers.
Explore Similar Insights
Molecular Cytogenetics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
